Spectral properties and mechanisms that underlie autofluorescent accumulations in Batten disease

Biochemical and Biophysical Research Communications

Volumn 382, Issue 2, 2009, Pages 247-251

  Seehafer, Sabrina S ^a   Pearce, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Autofluorescent storage material; Microtubule assembly; Neuronal Ceroid Lipofuscinosis; Non muscle myosin II

Indexed keywords

MYOSIN II;

ARTICLE; AUTOFLUORESCENCE; AUTOPHAGY; CELL DISRUPTION; CELL ORGANELLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYMPHOBLAST; LYSOSOME; MICROTUBULE ASSEMBLY; NEURONAL CEROID LIPOFUSCINOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADOLESCENT; ADULT; CELL AGING; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORESCENCE; HUMANS; LYSOSOMES; MALE; MICROTUBULES; MYOSIN TYPE II; NEURONAL CEROID-LIPOFUSCINOSES; SPECTROMETRY, FLUORESCENCE;

EID: 63349086264     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.099     Document Type: Article

References (23)

1. Goebel H.H. The neuronal ceroid-lipofuscinoses. J. Child Neurol. 10 (1995) 424-437
2. Ramirez-Montealegre D., Rothberg P.G., and Pearce D.A. Another disorder finds its gene. Brain 129 (2006) 1353-1356
3. Kohlschutter A., Gardiner R.M., and Goebel H.H. Human forms of neuronal ceroid-lipofuscinosis (Batten disease): consensus on diagnostic criteria, Hamburg 1992. J. Inherit. Metab. Dis. 16 (1993) 241-244
4. Phillips S.N., Benedict J.W., Weimer J.M., and Pearce D.A. CLN3, the protein associated with batten disease: structure, function and localization. J. Neurosci. Res. 79 (2005) 573-583
5. Palmer D.N., Barns G., Husbands D.R., and Jolly R.D. Ceroid lipofuscinosis in sheep. II. The major component of the lipopigment in liver, kidney, pancreas, and brain is low molecular weight protein. J. Biol. Chem. 261 (1986) 1773-1777
6. Seehafer S.S., and Pearce D.A. You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiol. Aging 27 (2006) 576-588
7. Palmer D.N., Fearnley I.M., Walker J.E., Hall N.A., Lake B.D., Wolfe L.S., Haltia M., Martinus R.D., and Jolly R.D. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am. J. Med. Genet. 42 (1992) 561-567
8. 2-terminal sequence. J. Biol. Chem. 264 (1989) 5736-5740
9. Wall F.E., Stern M.P., Jenson H.B., and Moyer M.P. An efficient method for routine Epstein-Barr virus immortalization of human B lymphocytes. In Vitro Cell. Dev. Biol. Anim. 31 (1995) 156-159
10. Platt J.L., and Michael A.F. Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J. Histochem. Cytochem. 31 (1983) 840-842
11. Palmer D.N., Jolly R.D., van Mil H.C., Tyynela J., and Westlake V.J. Different patterns of hydrophobic protein storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease). Neuropediatrics 28 (1997) 45-48
12. Definitions of Ultrastructure Patterns found in NCL, The Neuronal Ceroid Lipofuscinoses (Batten Disease), IOS Press, Netherlands, 1999, pp. 5-15.
13. Elleder M., Voldrich L., Ulehlova L., Dimitt S., and Armstrong D. Light and electron microscopic appearance of the inner ear in juvenile ceroid lipofuscinosis (CL). Pathol. Res. Pract. 183 (1988) 301-307
14. Rich D.H., Bernatowicz M.S., Agarwal N.S., Kawai M., Salituro F.G., and Schmidt P.G. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition. Biochemistry 24 (1985) 3165-3173
15. Drose S., and Altendorf K. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200 (1997) 1-8
16. Klempner M.S., and Styrt B. Alkalinizing the intralysosomal pH inhibits degranulation of human neutrophils. J. Clin. Invest. 72 (1983) 1793-1800
17. Weimer J.M., Kriscenski-Perry E., Elshatory Y., and Pearce D.A. The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease. Neuromolecular Med. 1 (2002) 111-124
18. Palombella V.J., Rando O.J., Goldberg A.L., and Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78 (1994) 773-785
19. Yoshida M., Kijima M., Akita M., and Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265 (1990) 17174-17179
20. Caro L.H., Plomp P.J., Wolvetang E.J., Kerkhof C., and Meijer A.J. 3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism. Eur. J. Biochem. 175 (1988) 325-329
21. Lee J.C., Field D.J., and Lee L.L. Effects of nocodazole on structures of calf brain tubulin. Biochemistry 19 (1980) 6209-6215
22. Coue M., Brenner S.L., Spector I., and Korn E.D. Inhibition of actin polymerization by latrunculin A. FEBS Lett. 213 (1987) 316-318
23. Limouze J., Straight A.F., Mitchison T., and Sellers J.R. Specificity of blebbistatin, an inhibitor of myosin II. J. Muscle Res. Cell Motil. 25 (2004) 337-341